#1 - Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
NASDAQ:ABLLL - See Stock Forecast- Stock Price:
- $26.50 (-$0.04)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
#2 - Edoc Acquisition
NASDAQ:ADOCR - See Stock Forecast- Stock Price:
- $0.27 (+$0.07)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Edoc Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the healthcare and healthcare provider space in North America and the Asia-Pacific. Edoc Acquisition Corp. was incorporated in 2020 and is based in Victor, New York.
#3 - Aimei Health Technology
NASDAQ:AFJKR - See Stock Forecast- Stock Price:
- $0.23
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
#4 - Argo Blockchain plc 8.75% Senior Notes due 2026
NASDAQ:ARBKL - See Stock Forecast- Stock Price:
- $8.75 (-$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
say hello to the future. argo makes it easy to mine bitcoin gold, ethereum and other altcoins from home. argo is a platform that enables customers to efficiently mine ethereum and other altcoins from their own computer or mobile device. with just a click of a button and a transparent monthly fee, our users can immediately select which coin(s) they want to mine. our service provides immediate access to argo's cutting-edge mining rigs, which seamlessly perform the complex crypto-mining operations for our users and then directly deposit all coins mined into users' digital wallets.
#5 - Arisz Acquisition
NASDAQ:ARIZR - See Stock Forecast- Stock Price:
- $0.32 (+$0.08)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Arisz Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to pursue targets in the healthcare industry in North America and Europe. The company was incorporated in 2021 and is based in New York, New York.
#6 - Atlas
NASDAQ:ATCOL - See Stock Forecast- Stock Price:
- $25.00
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Atlas Corp. operates as an asset manager and operator of containerships. The company, through its subsidiaries, operates as an independent charter owner and manager of containerships. The company charters its containerships under long-term and fixed-rate time charters to various container liner companies. It also provides electricity to oil and gas, mining, and other industries, as well as government backed and private utilities; and power solutions comprising plant design, fast-tracked installation of generating equipment and balance of plant, plant operation, and service and maintenance. As of March 10, 2022, the company operated a fleet of 132 vessels, 30 gas turbines, and 414 diesel generators. Atlas Corp. was incorporated in 2019 and is based in London, the United Kingdom.
#7 - Atlanticus Holdings Co. 6.125% Senior Notes due 2026
NASDAQ:ATLCL - See Stock Forecast- Stock Price:
- $23.87 (+$0.18)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
atlanticus holdings corporation ("atlanticus") is a financial holding company with investments primarily in companies focused on providing financial services. our subsidiaries offer a broad array of financial products and services. www.atlanticus.com
#8 - AlphaTime Acquisition
NASDAQ:ATMCR - See Stock Forecast- Stock Price:
- $0.17 (-$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
AlphaTime Acquisition Corp intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
#9 - BFC Capital Trust II PFD TR 7.20%
NASDAQ:BANFP - See Stock Forecast- Stock Price:
- $26.04
- Dividend Yield:
- 6.55%
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
#10 - Bayview Acquisition
NASDAQ:BAYAR - See Stock Forecast- Stock Price:
- $0.20
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
We are a blank check company incorporated on February 16, 2023 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While a majority of our executive officers and directors are located in or have significant ties to the People's Republic of China, including, solely for purposes of this prospectus, Hong Kong, Taiwan and Macau, which we refer to throughout this prospectus collectively as the “PRC,” a majority of our executive officers and directors are citizens of the United States or Canada. Our Chief Executive Officer, Xin Wang, is a Canadian citizen and our Chief Financial Officer, David Bamper, is a United States citizen and two of our directors are United States citizens, resulting in three of our six executive officers and directors being United States citizens. Our Sponsors, Bayview Holding LP and Peace Investment Holdings Limited are each located in New York, NY, USA and Dongguan, Guangdong Province, People's Republic of China, respectively. While a majority of our executive officers and directors are citizens of the United States or Canada, our ties to China present legal and operational risks to us and our investors, including significant risks related to actions that may be taken by China in the areas of regulatory, liquidity and enforcement, which exist and are independent of the legal and operational risks that ties to China or Hong Kong may present in connection with effecting an initial business combination. For example, if these ties were to cause China to view us as subject to their regulatory authority, China could take actions that could materially hinder or prevent our offering of securities to investors, materially change our operations and/or the value of the securities we are registering, and cause the value of such securities to significantly decline or be worthless. In addition, our executive officers' and directors' ties to China may make us a less attractive partner to potential target companies outside the PRC than a non-PRC related SPAC. As a result, we are more likely to acquire a company based in China in an initial business combination. If we decide to consummate our initial business combination with a target business based in and primarily operating in China, the combined company may face various legal and operational risks and uncertainties after the business combination. In order to reduce or limit such risks, we will not consider or undertake an initial business combination with any company with financial statements audited by an accounting firm that the PCAOB has been unable to inspect for two consecutive years. Further, due to (i) the risks associated with acquiring and operating a business in the PRC and/or Hong Kong, and (ii) the fact that our executive officers and directors are located in or have significant ties to China, it may make us a less attractive partner to certain potential target businesses, including non-China- or non-Hong Kong-based target companies. In the event that we determine to pursue a business combination with a target company based in China or Hong Kong, we may become subject to legal and operational risks resulting from Chinese laws and regulations that are sometimes vague and uncertain, and which may therefore, present risks that may result in a material change in the combined company's principal operations in China, significant depreciation of the value of the combined company's securities, or which may materially hinder or prevent the offering of securities by the combined company to investors and cause the value of such securities to significantly decline or be worthless. The PRC government has significant authority to exert influence on the ability of a China-based company to conduct its business, make or accept foreign investments or list on a U.S. stock exchange. For example, if we enter into a business combination with a target business operating in China, the combined company may face risks associated with regulatory approvals of the proposed business combination between us and the target, offshore offerings, anti-monopoly regulatory actions, cybersecurity and data privacy, as well as the lack of PCAOB inspection of its auditors or the auditors of the target business. In addition, the combined company may be subject to legal and operational risks associated with having substantially all of its operations in China, including risks related to the legal, political and economic policies of the Chinese government, the relations between China and the United States, or Chinese or United States regulations, which risks could result in a material change in the combined company's operations and/or the value of the securities of the combined company. As indicated above, while we intend to focus our search on businesses in Asia, we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination. Because our management team has a substantial network in the PRC, we may pursue a business combination with a company doing business in China, which may have legal and operational risks associated with such a decision. These risks could result in a material change in the target company's post-combination operations or could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or become worthless. However, we will not consummate our initial business combination with an entity or business with China operations consolidated through a VIE structure. Since a majority of our executive officers and directors are located in or have significant ties to the PRC, we may be a less attractive partner to potential target companies outside the PRC, thereby limiting our pool of acquisition candidates. This would impact our search for a target company and make it harder for us to complete an initial business combination with a non-China-based target company. For example, a combination with a U.S. target company may be subject to review by a U.S. government entity or may ultimately be prohibited. Furthermore, the additional time that could be required for governmental review of the transaction or complete prohibition of the transaction could prevent us from completing an initial business combination and require us to liquidate. In the event of liquidation, investors would lose their investment opportunity in potential target companies, any price appreciation in a combined company, and their financial investment in the rights, which would expire worthless. See “Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination — Our ability to complete a business combination may be impacted by the fact that some of our officers and directors are located in or have significant ties to the People's Republic of China, including, Hong Kong, Taiwan and Macau. This may make us a less attractive partner to potential target companies outside the PRC, thereby limiting our pool of acquisition candidates and making it harder for us to complete an initial business combination with a non-China-based target company. For example, we may not be able to complete an initial business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.” We believe our management team is well positioned to identify attractive risk-adjusted returns in the marketplace and that our professional contacts and transaction sources, ranging from industry executives, private owners, private equity funds, family offices, commercial and investment bankers, lawyers and other financial sector service providers and participants, in addition to the geographical reach of our affiliates, will enable us to pursue a broad range of opportunities. Our management believes that its collective ability to identify and implement value creation initiatives has been an essential driver of past performance and will remain central to its differentiated acquisition strategy. Our executive offices are located at 420 Lexington Ave Suite 2446, New York, NY.
#11 - Bayview Acquisition
NASDAQ:BAYAU - See Stock Forecast- Stock Price:
- $10.80
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
We are a blank check company incorporated on February 16, 2023 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While a majority of our executive officers and directors are located in or have significant ties to the People's Republic of China, including, solely for purposes of this prospectus, Hong Kong, Taiwan and Macau, which we refer to throughout this prospectus collectively as the “PRC,” a majority of our executive officers and directors are citizens of the United States or Canada. Our Chief Executive Officer, Xin Wang, is a Canadian citizen and our Chief Financial Officer, David Bamper, is a United States citizen and two of our directors are United States citizens, resulting in three of our six executive officers and directors being United States citizens. Our Sponsors, Bayview Holding LP and Peace Investment Holdings Limited are each located in New York, NY, USA and Dongguan, Guangdong Province, People's Republic of China, respectively. While a majority of our executive officers and directors are citizens of the United States or Canada, our ties to China present legal and operational risks to us and our investors, including significant risks related to actions that may be taken by China in the areas of regulatory, liquidity and enforcement, which exist and are independent of the legal and operational risks that ties to China or Hong Kong may present in connection with effecting an initial business combination. For example, if these ties were to cause China to view us as subject to their regulatory authority, China could take actions that could materially hinder or prevent our offering of securities to investors, materially change our operations and/or the value of the securities we are registering, and cause the value of such securities to significantly decline or be worthless. In addition, our executive officers' and directors' ties to China may make us a less attractive partner to potential target companies outside the PRC than a non-PRC related SPAC. As a result, we are more likely to acquire a company based in China in an initial business combination. If we decide to consummate our initial business combination with a target business based in and primarily operating in China, the combined company may face various legal and operational risks and uncertainties after the business combination. In order to reduce or limit such risks, we will not consider or undertake an initial business combination with any company with financial statements audited by an accounting firm that the PCAOB has been unable to inspect for two consecutive years. Further, due to (i) the risks associated with acquiring and operating a business in the PRC and/or Hong Kong, and (ii) the fact that our executive officers and directors are located in or have significant ties to China, it may make us a less attractive partner to certain potential target businesses, including non-China- or non-Hong Kong-based target companies. In the event that we determine to pursue a business combination with a target company based in China or Hong Kong, we may become subject to legal and operational risks resulting from Chinese laws and regulations that are sometimes vague and uncertain, and which may therefore, present risks that may result in a material change in the combined company's principal operations in China, significant depreciation of the value of the combined company's securities, or which may materially hinder or prevent the offering of securities by the combined company to investors and cause the value of such securities to significantly decline or be worthless. The PRC government has significant authority to exert influence on the ability of a China-based company to conduct its business, make or accept foreign investments or list on a U.S. stock exchange. For example, if we enter into a business combination with a target business operating in China, the combined company may face risks associated with regulatory approvals of the proposed business combination between us and the target, offshore offerings, anti-monopoly regulatory actions, cybersecurity and data privacy, as well as the lack of PCAOB inspection of its auditors or the auditors of the target business. In addition, the combined company may be subject to legal and operational risks associated with having substantially all of its operations in China, including risks related to the legal, political and economic policies of the Chinese government, the relations between China and the United States, or Chinese or United States regulations, which risks could result in a material change in the combined company's operations and/or the value of the securities of the combined company. As indicated above, while we intend to focus our search on businesses in Asia, we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination. Because our management team has a substantial network in the PRC, we may pursue a business combination with a company doing business in China, which may have legal and operational risks associated with such a decision. These risks could result in a material change in the target company's post-combination operations or could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or become worthless. However, we will not consummate our initial business combination with an entity or business with China operations consolidated through a VIE structure. Since a majority of our executive officers and directors are located in or have significant ties to the PRC, we may be a less attractive partner to potential target companies outside the PRC, thereby limiting our pool of acquisition candidates. This would impact our search for a target company and make it harder for us to complete an initial business combination with a non-China-based target company. For example, a combination with a U.S. target company may be subject to review by a U.S. government entity or may ultimately be prohibited. Furthermore, the additional time that could be required for governmental review of the transaction or complete prohibition of the transaction could prevent us from completing an initial business combination and require us to liquidate. In the event of liquidation, investors would lose their investment opportunity in potential target companies, any price appreciation in a combined company, and their financial investment in the rights, which would expire worthless. See “Risk Factors — Risks Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination — Our ability to complete a business combination may be impacted by the fact that some of our officers and directors are located in or have significant ties to the People's Republic of China, including, Hong Kong, Taiwan and Macau. This may make us a less attractive partner to potential target companies outside the PRC, thereby limiting our pool of acquisition candidates and making it harder for us to complete an initial business combination with a non-China-based target company. For example, we may not be able to complete an initial business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.” We believe our management team is well positioned to identify attractive risk-adjusted returns in the marketplace and that our professional contacts and transaction sources, ranging from industry executives, private owners, private equity funds, family offices, commercial and investment bankers, lawyers and other financial sector service providers and participants, in addition to the geographical reach of our affiliates, will enable us to pursue a broad range of opportunities. Our management believes that its collective ability to identify and implement value creation initiatives has been an essential driver of past performance and will remain central to its differentiated acquisition strategy. Our executive offices are located at 420 Lexington Ave Suite 2446, New York, NY.
#12 - Brighthouse Financial
NASDAQ:BHFAL - See Stock Forecast- Stock Price:
- $24.69 (+$0.10)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Brighthouse Financial, Inc. operates as a holding company, which engages in the provision of life insurance and annuities through independent distribution channels and marketing arrangements with diverse network of distribution partners. It operates through the following segments: Annuities; Life; Run-Off; and Corporate & Others. The Annuities segment product offerings include fixed, structured, income and variable annuities. The Life segment manufactures products to serve its target segments through a broad independent distribution network. The Run-Off segment includes structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and universal life with secondary guarantees. The Corporate & Other segment refers to the general account investments and the separate account assets of the company. The company was founded June 1863 and is headquartered in Charlotte, NC.
#13 - Bellevue Life Sciences Acquisition
NASDAQ:BLACR - See Stock Forecast- Stock Price:
- $0.12
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
#14 - bleuacacia
NASDAQ:BLEUR - See Stock Forecast- Stock Price:
- $0.01 (-$0.01)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
bleuacacia ltd does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of premium branded consumer retail. The company was incorporated in 2021 and is based in New York, New York.
#15 - Popular Capital Trust II PFD GTD 6.125%
NASDAQ:BPOPM - See Stock Forecast- Stock Price:
- $25.74 (+$0.49)
- Dividend Yield:
- 6.55%
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Popular, Inc., through its subsidiaries, provides various retail, mortgage, and commercial banking products and services in Puerto Rico, the United States, and British Virgin Islands. The company provides savings, NOW, money market, and other interest-bearing demand accounts; non-interest bearing demand deposits; and certificates of deposit. It also offers commercial and industrial, commercial multi-family, commercial real estate, and residential mortgage loans; consumer loans, including personal loans, credit cards, automobile loans, home equity lines of credit, and other loans to individual borrowers; construction loans; and lease financing comprising automobile loans/leases. In addition, the company provides investment banking, auto and equipment leasing and financing, broker-dealer, and insurance services; debit cards; and online banking services. As of December 31, 2021, it operated 169 branches; and 616 ATMs in Puerto Rico, 23 ATMs in the Virgin Islands, and 91 ATMs in the United States Mainland. Popular, Inc. was founded in 1893 and is headquartered in Hato Rey, Puerto Rico.
#16 - Brookfield Property Preferred
NASDAQ:BPYPM - See Stock Forecast- Stock Price:
- $16.75 (-$0.01)
- Dividend Yield:
- 12.00%
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Brookfield Property Partners LP invests in real estate. The Company owns, operates and invests in commercial properties. Brookfield Property Partners focuses on properties located in North America, Europe, Australia and Brazil.
#17 - Broad Capital Acquisition
NASDAQ:BRACR - See Stock Forecast- Stock Price:
- $0.11 (-$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Broad Capital Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2021 and is based in Dallas, Texas.
#18 - Brilliant Acquisition
NASDAQ:BRLIR - See Stock Forecast- Stock Price:
- $0.45 (+$0.15)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Brilliant Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Brilliant Acquisition Corporation was incorporated in 2019 and is based in Shanghai, China.
#19 - Blue World Acquisition
NASDAQ:BWAQR - See Stock Forecast- Stock Price:
- $0.23 (-$0.03)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Blue World Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus primarily on businesses in the marine leisure, cruise, marine infrastructure and engineering, general hospitality, travel and tourism, marine services, logistics and supply chain, offshore energy solutions, and related industry segments. Blue World Acquisition Corporation was incorporated in 2021 and is based in New York, New York.
#20 - Cetus Capital Acquisition
NASDAQ:CETUR - See Stock Forecast- Stock Price:
- $0.35 (+$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Cetus Capital Acquisition Corp. is a blank check company. The company focuses on merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Cetus Capital Acquisition Corp. was incorporated in 2022 and is based in Taipei, Taiwan. Cetus Capital Acquisition Corp. operates as a subsidiary of Cetus Sponsor LLC.
#21 - Carlyle Group Inc. 4.625% Subordinated Notes due 2061
NASDAQ:CGABL - See Stock Forecast- Stock Price:
- $19.46 (-$0.04)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company's first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs t
#22 - Carlyle Secured Lending, Inc. 8.20% Notes due 2028
NASDAQ:CGBDL - See Stock Forecast- Stock Price:
- $25.46 (+$0.03)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
#23 - Chicken Soup for the Soul Enter
NASDAQ:CSSEN - See Stock Forecast- Stock Price:
- $0.00
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
chicken soup for the soul entertainment's mission is to bring out the best of the human spirit by curating and sharing entertaining video stories of hope, comfort and positivity. as a next-generation media company, our goal is to expand our content offerings and distribution capabilities to new and emerging platforms so that we can bring the inspiring and uplifting chicken soup for the soul message to as many people as possible.
#24 - Capital Southwest
NASDAQ:CSWCZ - See Stock Forecast- Stock Price:
- $25.69 (-$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Capital Southwest Corporation is a business development company specializing in credit and private equity and venture capital investments in middle market companies, mezzanine, later stage, mature, late venture, emerging growth, buyouts, recapitalizations and growth capital investments. It does not invest in startups, publicly traded companies, real estate developments, project finance opportunities, oil and gas exploration businesses, troubled companies, turnarounds, and companies in which significant senior management is departing. In lower middle market, the firm typically invests in growth financing, bolt-on acquisitions, new platform acquisitions, refinancing, dividend recapitalizations, sponsor-led buyouts, and management buyouts situations. The investment structures are Unitranche debt, subordinated debt, senior debt, first and second lien debt, and preferred and common equity. The firm makes equity co-investments alongside debt investments, up to 20% of total check and only makes non-control investments. It prefers to invest in Industrial manufacturing and services, value-added distribution, healthcare products and services, business services, specialty chemicals, food and beverage, tech-enabled services and SaaS models. The firm seeks to invest in energy services and products, industrial technologies, and specialty chemicals and products. Within energy services and products, the firm seeks to invest in each segment of the industry, including upstream, midstream and downstream, excluding exploration and production with a focus on differentiated products and services, equipment and tool rental, consumable products, and drilling and completion chemicals. Within industrial technologies, it seeks to invest in automation and process controls, handling and packaging equipment, industrial filtration and fluid handling, measurement, monitoring and testing, professional tools, and sensors and instrumentation. Within and specialty chemicals and products, the firm seeks to invest in businesses that develop and manufacture highly differentiated chemicals and products including adhesives, coatings and sealants, catalysts and absorbents, cosmeceuticals, fine chemicals, flavors and fragrances, performance lubricants, polymers, plastics and composites, chemical dispensing and filtration equipment, professional and industrial trade consumables and tools, engineered solutions for HVAC, plumbing, and electrical installations, specified high performance materials for fire protection and oilfield applications. It may also invest in exceptional opportunities in building products. The firm seeks to invest in the United States. The firm seeks to make investments ranging from $5 to $25 million in securities. It seeks to make equity investments ranging from $5 million to $50 million and debt investments between $5 million and $20 million and co-invest in transaction size up to $40 million. It prefers to invest in companies with revenues approaching above $10 million, profitable operations, historical growth rate of at least 15 percent per year. Within the lower middle market, it seeks to invest in with less than $15 million in EBITDA and also opportunistically invests in the upper middle market, generally defined as companies with EBITDA in excess of $50 million. In addition to making direct investments, the firm allocates capital to syndicated first and second lien term loans in the upper middle market. Criteria for Upper Middle Market Syndicated 1st Lien is EBITDA Size more than $30 million, Closing Leverage greater than 4 times, investment hold size between $5 million and $7 million, investment yield greater than 6.5%. Criteria for Upper Middle Market Syndicated 2nd Lien is EBITDA Size more than $50 million, Closing Leverage greater than 6 times, investment hold size between $5 million and $7 million, investment yield greater than 9%. It prefers to take a majority and minority stake. The firm has the flexibility to hold investments for very long period in its portfolio companies. It may also invest through warrants. The firm prefers to take Board participation in its portfolio companies. Capital Southwest Corporation was founded on April 19, 1961 and is based in Dallas, Texas.
#25 - Dillards Capital Trust I CAP SECS 7.5%
NYSE:DDT - See Stock Forecast- Stock Price:
- 25.93 (+0.03)
- Dividend Yield:
- 7.33%
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Dillard's, Inc. operates retail department stores in the southeastern, southwestern, and midwestern areas of the United States. Its stores offer merchandise, including fashion apparel for women, men, and children; and accessories, cosmetics, home furnishings, and other consumer goods. As of January 29, 2022, the company operated 280 Dillard's stores, including 30 clearance centers, and an Internet store at dillards.com. It also engages in the general contracting construction activities. The company was founded in 1938 and is based in Little Rock, Arkansas.
#26 - Diversified Healthcare Trust
NASDAQ:DHCNI - See Stock Forecast- Stock Price:
- $15.28 (-$0.02)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
#27 - Distoken Acquisition
NASDAQ:DISTR - See Stock Forecast- Stock Price:
- $0.11
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Distoken Acquisition Corporation does not have significant operations. The company focus on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. It intends to focus on businesses in the technology industry that operates in Asia. The company was incorporated in 2020 and is based in Kunming, China.
#28 - ESH Acquisition
NASDAQ:ESHAR - See Stock Forecast- Stock Price:
- $0.06 (-$0.01)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
ESH Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets in the sports, hospitality, and music and entertainment sectors. The company was incorporated in 2021 and is based in New York, New York.
#29 - Fintech Ecosystem Development
NASDAQ:FEXDR - See Stock Forecast- Stock Price:
- $0.00 (-$0.00)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Fintech Ecosystem Development Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the financial technology development sector in South Asia. Fintech Ecosystem Development Corp. was incorporated in 2021 and is based in Collegeville, Pennsylvania.
#30 - Feutune Light Acquisition
NASDAQ:FLFVR - See Stock Forecast- Stock Price:
- $0.23 (+$0.03)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Feutune Light Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2022 and is based in Metuchen, New Jersey.
#31 - Fossil Group, Inc. 7% Senior Notes due 2026
NASDAQ:FOSLL - See Stock Forecast- Stock Price:
- $13.62 (+$0.08)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
fossil group, inc. is a global design, marketing, distribution and innovation company specializing in lifestyle accessories. under a diverse portfolio of owned and licensed brands, our offerings include fashion watches, jewelry, handbags, small leather goods and wearables. with our newest owned brand, misfit, we're bringing style and technology to the high-growth connected space. we're committed to delivering the best in design and innovation across our owned brands, fossil, michele, misfit, relic, skagen and zodiac, and licensed brands, adidas, armani exchange, burberry, chaps, diesel, dkny, emporio armani, karl lagerfeld, kate spade new york, marc jacobs, michael kors and tory burch. we bring each brand story to life through an extensive wholesale distribution network across 150 countries and over 600 retail locations. (nasdaq: fosl)
#32 - Gladstone Investment Co. 8.00% Notes due 2028
NASDAQ:GAINL - See Stock Forecast- Stock Price:
- $26.00 (+$0.29)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
gladstone investment corporation (nasdaq: gain), a business development company (“bdc”), is a private equity fund focused on acquiring mature, lower middle market companies with attractive fundamentals and strong management teams. as a publicly-traded bdc, gain provides both equity and debt capital, which greatly increases certainty and speed of closing as well as provides gain's shareholders with both current yield in the form of monthly dividends and potential capital gains upside. in addition to providing most, if not all, of the equity and debt capital required to close a transaction, gain has no partnership end-of-life deadlines and can structure investments in line with the long-term needs of the businesses we invest in. by providing truly patient, long-term capital, gain is a value-added partner to the companies we invest in. we are a part of the gladstone companies, which includes three other affiliated publicly-traded companies: gladstone capital corporation (nasdaq: glad) a b
#33 - Gladstone Investment Co. 5.00% Notes Due 2026
NASDAQ:GAINN - See Stock Forecast- Stock Price:
- $24.40 (-$0.05)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
gladstone investment corporation (nasdaq: gain), a business development company (“bdc”), is a private equity fund focused on acquiring mature, lower middle market companies with attractive fundamentals and strong management teams. as a publicly-traded bdc, gain provides both equity and debt capital, which greatly increases certainty and speed of closing as well as provides gain's shareholders with both current yield in the form of monthly dividends and potential capital gains upside. in addition to providing most, if not all, of the equity and debt capital required to close a transaction, gain has no partnership end-of-life deadlines and can structure investments in line with the long-term needs of the businesses we invest in. by providing truly patient, long-term capital, gain is a value-added partner to the companies we invest in. we are a part of the gladstone companies, which includes three other affiliated publicly-traded companies: gladstone capital corporation (nasdaq: glad) a b
#34 - Gladstone Investment Co. 4.875% Notes due 2028
NASDAQ:GAINZ - See Stock Forecast- Stock Price:
- $23.58
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
gladstone investment corporation (nasdaq: gain), a business development company (“bdc”), is a private equity fund focused on acquiring mature, lower middle market companies with attractive fundamentals and strong management teams. as a publicly-traded bdc, gain provides both equity and debt capital, which greatly increases certainty and speed of closing as well as provides gain's shareholders with both current yield in the form of monthly dividends and potential capital gains upside. in addition to providing most, if not all, of the equity and debt capital required to close a transaction, gain has no partnership end-of-life deadlines and can structure investments in line with the long-term needs of the businesses we invest in. by providing truly patient, long-term capital, gain is a value-added partner to the companies we invest in. we are a part of the gladstone companies, which includes three other affiliated publicly-traded companies: gladstone capital corporation (nasdaq: glad) a b
#35 - Great Elm Capital Corp. - 6.75%
NASDAQ:GECCM - See Stock Forecast- Stock Price:
- $25.03 (+$0.01)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Great Elm Capital Corp. is an externally managed, specialty finance company focused on investing in debt instruments of middle market companies. GECC elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. GECC seeks to generate attractive, risk-adjusted returns through both current income and capital appreciation.
#36 - Great Elm Capital Corp. 5.875% Notes due 2026
NASDAQ:GECCO - See Stock Forecast- Stock Price:
- $24.85 (+$0.05)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Great Elm Capital Corp. is an externally managed, specialty finance company focused on investing in debt instruments of middle market companies. GECC elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. GECC seeks to generate attractive, risk-adjusted returns through both current income and capital appreciation.
#37 - Great Elm Capital Corp. 8.75% Notes due 2028
NASDAQ:GECCZ - See Stock Forecast- Stock Price:
- $25.51
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
great elm capital corp. (nasdaq: gecc, “gecc”) is an externally managed, specialty finance company focused on investing in the debt instruments of middle market companies. gecc has elected to be regulated as a business development company (“bdc”) under the investment company act of 1940, as amended. gecc is managed by great elm capital management (“gecm”). gecm's investment team has deployed more than $17 billion into more than 550 issuers across 20+ jurisdictions over the team's 14 year history under mast capital management, llc. now led by peter a. reed, gecc's chief executive officer, gecm's investment team has more than 100 years of aggregate experience financing and investing in leveraged middle market companies. investment objective: gecc's investment objective is to generate both current income and capital appreciation, while seeking to protect against risk of permanent capital loss. gecc will invest predominantly in the debt securities of middle market companies, which gecm def
#38 - Great Elm Group, Inc. 7.25% Notes due 2027
NASDAQ:GEGGL - See Stock Forecast- Stock Price:
- $24.00
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
the great elm capital management (“gecm”) investment team has deep experience investing in leveraged middle market companies. the gecm team has deployed more than $17 billion into credit investments in more than 550 issuers across 20+ jurisdictions over its 14-year history under mast capital management, llc (“mast”). led by peter a. reed, gecm's investment team has more than 100 years of experience in the aggregate financing and investing in leveraged middle market companies. great elm's first investment vehicle is great elm capital corp. (“gecc”), a business development company. for more information, please visit: www.greatelmcc.com.
#39 - Gladstone Capital Co. 7.75% Notes due 2028
NASDAQ:GLADZ - See Stock Forecast- Stock Price:
- $25.22 (+$0.03)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
leaders in private equity, debt and real estate ownership and financing, the gladstone companies are a family of public investment funds. our funds as applicable, invest in commercial real estate, farmland, and small and medium-sized companies and provide financing to such businesses across the capital structure, from second lien and mezzanine debt, to equity and real estate financing solutions. financing for the gladstone companies is provided by four public investment vehicles: gladstone capital corporation (nasdaq: glad), gladstone investment corporation (nasdaq: gain), gladstone commercial corporation (nasdaq: good), and gladstone land corporation (nasdaq: land). target investments generally range from $5 to $30 million in companies with over $3 million in ebitda. target industries: light and specialty manufacturing, industrial products and services, business and government services, aerospace and defense, media and communications, consumer products and services, healthcare service
#40 - Global Star Acquisition, Inc. Right
NASDAQ:GLSTR - See Stock Forecast- Stock Price:
- $0.17
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
#41 - Gladstone Commercial
NASDAQ:GOODO - See Stock Forecast- Stock Price:
- $22.03 (-$0.03)
- Dividend Yield:
- 7.41%
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
gladstone commercial corporation is a publicly traded reit (nasdaq: good) that invests in single tenant and anchored multi-tenant net leased industrial, office and, to a lesser extent, medical properties nationwide. we also invest alongside developers in build-to-suit transactions where a tenant requires a new building. we buy properties with strong tenants of all sizes and we believe our track record of underwriting the credit of middle market businesses is unmatched. we target primary and secondary growth markets that possess favorable economic growth trends, diversified industries, growing populations, and strong employment. our senior management team, under the guidance of david gladstone, has over 200 years of combined experience investing in real estate and middle market businesses. we have a track record of success, as exhibited by a history of strong distribution yields, consistent occupancy greater than 96.0%, and 10+ years of paying continuous monthly cash distributions. we a
#42 - Greenidge Generation Holdings Inc. 8.50% Senior Notes due 2026
NASDAQ:GREEL - See Stock Forecast- Stock Price:
- $10.01 (+$0.51)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Greenidge Generation Holdings Inc. operates as an integrated cryptocurrency datacenter and power generation company. The company owns and operates cryptocurrency datacenters in New York and South Carolina. It also owns and operates a 106 MW power generation facility. The company was founded in 1937 and is based in Fairfield, Connecticut.
#43 - Hennessy Advisors, Inc. 4.875% Notes due 2026
NASDAQ:HNNAZ - See Stock Forecast- Stock Price:
- $24.05 (+$0.07)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
hennessy advisors, inc. is the publicly traded investment manager of the hennessy funds. the company serves clients with integrity, honesty and candor. hennessy advisors' strength lies in their disciplined investment style and commitment to managing their mutual funds for the benefit of their shareholders.
#44 - Harrow Health, Inc. 8.625% Senior Notes due 2026
NASDAQ:HROWL - See Stock Forecast- Stock Price:
- $25.30 (-$0.08)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas
#45 - Harrow Health, Inc. 11.875% Senior Notes due 2027
NASDAQ:HROWM - See Stock Forecast- Stock Price:
- $26.34 (+$0.03)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas
#46 - Horizon Space Acquisition I
NASDAQ:HSPOR - See Stock Forecast- Stock Price:
- $0.09
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
Horizon Space Acquisition I Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. Horizon Space Acquisition I Corp. was incorporated in 2022 and is based in New York, New York.
#47 - Hancock Whitney Co. - 6
NASDAQ:HWCPZ - See Stock Forecast- Stock Price:
- $24.88 (+$0.06)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
since the late 1800s, hancock bank has embodied core values of honor & integrity, strength & stability, commitment to service, teamwork, and personal responsibility. at locations in mississippi, alabama, and florida, hancock bank offers a comprehensive array of financial products and services, including traditional and online banking; commercial and small business banking; energy banking; private banking; trust and investment services; certain insurance services; and mortgage services. we strive to offer rewarding employment and career opportunities in support of our core values. we welcome your interest and invite you to explore employment opportunities with our company. equal opportunity/affirmative action employers. all qualified applicants will receive consideration for employment without regard to race, color, religious beliefs, national origin, ancestry, citizenship, sex, gender, sexual orientation, gender identity, marital status, age, physical or mental disability or histor
#48 - International Media Acquisition
NASDAQ:IMAQR - See Stock Forecast- Stock Price:
- $0.04
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
International Media Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the media and entertainment sector. International Media Acquisition Corp. was incorporated in 2021 and is based in North Brunswick, New Jersey.
#49 - First Internet Bancorp - Fixed-
NASDAQ:INBKZ - See Stock Forecast- Stock Price:
- $25.15 (-$0.43)
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A
first internet bancorp operates as the bank holding company for first internet bank of indiana that provides commercial and retail banking products and services in the united states. the company offers savings and money market accounts, non-interest bearing and interest-bearing demand deposits, brokered deposit accounts, and certificates of deposit. it also provides commercial and industrial, owner-occupied commercial real estate, investor commercial real estate, construction, residential mortgage, home equity, small installment, home improvement, term, and other consumer loans, as well as single tenant lease financing, public and healthcare finance, lines of credit, and letters of credit to individuals and commercial customers. in addition, the company is involved in the purchase, manage, service, and safekeeping of municipal securities; and offers municipal lending and leasing products to government entities. in addition, it provides corporate credit card and treasury management serv
#50 - Jaguar Global Growth Co. I
NASDAQ:JGGCR - See Stock Forecast- Stock Price:
- $0.14
- Consensus Rating:
- N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target:
- N/A